Vision Care Market to be worth USD 169.37 billion by 2032, Get Insights FMI

The vision care market is expected to grow at a decent CAGR of 7.3% during the forecast period. The valuation of the vision care market as on 2022 is US$ 83.72 billion, and the market is projected to be valued at US$ 169.37 billion by 2032.

The increasing usage of electronic devices, changing lifestyle and hygiene have led to vision-related problems worldwide. The number of patients with vision-related problems have increased and so is the need for vision care products and services.

Vision Care Market: Dynamics

According to the World Health Organization (WHO), approximately 285 million people are visually impaired worldwide. Out of these, 39 million people are blind and 246 million people have low vision. Most of the disorders & conditions causing visual impairment & blindness are preventable or readily treatable with known & cost-effective interventions, and normal vision can be restored with the help of eyeglasses, contact lenses or refractive surgery. Ageing is one of the prime factors responsible for vision-related problems. Population aged 65+ years is growing day by day and with it the demand for eye care-related products and solutions is also increasing.

This increasing ageing population and the growing demand for vision care products are factors expected to create growth opportunities for the manufacturers globally. Healthcare initiatives by the Federal health care programs have increased the number of population opting for vision care benefits. Besides, the out-of-pocket costs have reduced due to insurance coverage. Likewise, in the U.S., “The Patient Protection and Affordable Care Act” has defined eye care for pediatric as an essential benefit? This factor, in particular, is likely to play an instrumental role in driving the growth of the vision care market.

Request Sample Report:

https://www.futuremarketinsights.com/reports/sample/rep-gb-822

With a rapid increase in the internet usage, technological changes and number of research-based industries, the usage of laptops, mobiles, PCs and others electronic devices has increased in the day-to-day life, which is the major factor responsible for eye-related problems. To overcome this alarming situation, “VISION 2020 – The Right to Sight” a global action program is conducted by NGOs and private organizations in collaboration with the WHO to prevent avoidable blindness. Also, “VISION 2020” has initiated global campaigns to raise awareness among governments about the societal effects of blindness and to gather a strong, long-term political & professional commitment to reduce avoidable blindness. “VISION 2020” has taken initiatives to develop & strengthen the primary health/eye care methodology to prevent the avoidable blindness.

The growth of the vision care market is driven by the increase in lens prescriptions and eye care professionals such as optometrists and ophthalmologists. Most of the ageing consumers (65+) have low awareness regarding eye health. Product development, particularly for the ageing population, is a major challenge as ageing consumers tend to suffer from dry eyes due to which fitting of contact lens becomes difficult.

Therefore, the products for ageing consumers need more attention. Elderly population prefers spectacles over contact lens due to low awareness regarding their benefits. According to the company, the spectacle lenses segment accounted over 40% revenue share in the global vision care market in 2017. However, the growing popularity of contact lens might limit the segment’s growth in the near future. Contact lenses offer vision correction for the entire field of the eye including peripheral vision. Soft contact lenses are safe for daily use and for sports as well. They do not fog and can be discarded if damaged. Besides, they are economic compared to prescribed glasses.

Vision Care Market: Regional Insights

In Europe and Northern America, more than 1 person in 5 was aged 60 or above in 2017. According to a survey by the WHO, 90% of the visually impaired population is in low- & middle-income countries. A significant share of this population is unaware regarding the preventive care for vision loss, available curative services and quality rehabilitation.

Further, the growing number of ageing population with vision disorders in Asia Pacific is likely to boost the growth of the vision care market in Asia Pacific. Increasing geriatric population and rising disposable income in North America is expected to surge the demand for advanced vision care products and solutions. The North America vision care market is estimated to create an absolute $ opportunity worth US$ 21,735 Mn between 2018 and 2028.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-822

Vision Care Market: Segmental Analysis

The company has segmented the global vision care market into spectacle lenses, contact lenses and cleaning & disinfecting solutions. In terms of revenue, the spectacle lenses and contact lenses segments are expected to hold significant shares over the forecast period. In contrary, the cleaning & disinfecting solutions segment in the vision care market is expected to exhibit limited investment opportunities, in terms of revenue, through 2028.

Vision Care Market: Companies

The report tracks some of the key companies operating in the vision care market, such as Bausch and Lomb (Acq. by Valeant Pharmaceuticals), Alcon (sub. Novartis AG), CooperVision and Johnson & Johnson, LUXOTTICA GROUP, Essilor, ZEISS International, Safilo Group and Rodenstock.

Read Related Reports:

https://www.articlesfactory.com/my/articles/c1439cfb-39e0-485f-ab26-6f43ae7dc844

https://figma-bosnia.tribe.so/post/preterm-birth-prevention-and-management-market-overview-high-growth-opportu–63490f55b5c3a61acca9c417

https://club.vexanium.com/post/preterm-birth-prevention-and-management-market-forecast-2029-size-share-gro–63490f57845ff3e7fb7ecf5d

https://www.snipesocial.co.uk/posts/140739

https://akastars.com/post/261220_preterm-birth-prevention-and-management-market-size-scope-growth-competitive-ana.html

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

MRI Guided Neurosurgical Ablation Market to grow at a rate of 5% by 2028 | Get Customized Reports

The global MRI Guided Neurosurgical Ablation Market was at US$ 154 Mn in 2021, and is projected to reach US$ 216.3 Mn by 2028, rising at a CAGR of 5% from 2022 to 2028.

MRI-guided neurosurgical ablation uses MRI guided high intensity laser probe for the ablation of brain cancer cells. The device is designed for the treatment of brain tumors. The probe used in the system kills the target cancer cell leaving its neighbor cells unharmed. The patient undergo a surgery, a small blurr hole is created of the diameter of a pencil drilled through skull. MRI in the procedure is used to guide the probe till the target cell.  The technique involves emission of highly focused thermal energy to coagulate and kill the target cancer cells. The MRI guided procedure occurs in real time so that the procedure only targets the cancer cell and leave the surrounding tissue unharmed. This is technique is used for tissue that are hard to reach region in brain. MRI guided neurosurgical ablation is usually performed in thalamus, insula and basal ganglia of brain. The technique is more useful and the patient is recovered in several days but less days as compared to the open surgery method. MRI guided Neurosurgical ablation device is used in many brain related disorders such as: Radiation resistant tumor, radiation necrosis due to earlier radiation therapy, glioblastoma multiforme, gial tumor, mesial temporal lobe epilepsy and metastatic brain cancer etc.

The procedure includes a catheter in the tumor but, some cases require more than a catheter. More than one catheter is usually used to maximize the volume of tumor that can be ablated. In MRI guidance neurosurgical ablation device MRI is used to map the temperature of the patient’s brain while performing laser ablation. Neurosurgical ablation surgery is touted to have the highest level of accuracy. The small risk of missing target might results in causing bleeding, which can be minimized with the lasers hemostatic properties.

MRI Guided Neurological Ablation Market: Drivers and Restraints

The global MRI guided neurological ablation market is expected to be fueled by the advancement in the global image guided surgery technologies. The key drivers of the market are the increasing cases of brain tumors, growing ageing population, family history of any cancer and the changing lifestyle. As per the Globocan report in 2012, the incidence rate of brain cancer and nervous system cancer is 1.9% globally. The increasing government initiatives to diagnose and treat early stage cancers is also expected to fuel global MRI guided neurological ablation market. The lack of awareness, less experienced professionals, lack of reimbursement and high cost of MRI device due to high cost of liquid helium that used as a coolant in MRI device is expected to hinder the growth of the market.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-2514

MRI Guided Neurological Ablation Market: Segmentation

The MRI guided neurological ablation market is classified on the basis of product type, end user and geography.

Based on product type, the global MRI guided neurological ablation market is segmented into the following:

  • Probe
    • Tip Laser Probe
    • Directional Laser Probe
  • Fixation Ring
  • MRI Scanner
  • Fixation and Transport

Based on end user, the global MRI guided neurological ablation market is segmented into the following:

  • Hospitals
  • Diagnostic Imaging Centers
  • Research Institutes

MRI Guided Neurological Ablation Market: Overview

The ongoing advancement in the imaging technique is expected to drive the market of MRI guided neurological ablation. MRI guided Neurological Ablation system contains probes, fixation rings, MRI scanner and fixation and transport system. Laser probes are of two types directional and tip laser device.  A normal laser prober contains directional fiber from where the beam of laser exit, thermo-couple, CO2 cooling tube and probe shaft. Fixation ring is removal and adjustable. Head fixation ring can be rotated and fixed for a flexible positioning of patients head. Fixation and transport system includes transfer system which is used for positioning patients head to the MRI scanner system and head ring. This device allows the surgeons for easy handling of target cancer cell in the brain and helps avoiding any harmful side effects.  This advancement in in the imaging technique is increasing the usage of these systems for treatment purposes. The increasing trained surgeons and awareness among the patients is expected to increase the growth of the market. The Hospital end user segment is expected to have maximum share in the market and is also expected to remain in with the maximum share.

Inquire Before Buying This Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-2514

MRI Guided Neurological Ablation Market: Regional Overview

Region wise, the global Colonoscopy market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America dominated the global market for MRI guided neurological ablation due to better experts, better reimbursement and awareness among the common people followed by Europe. The growing adoption of these device by the Neurosurgeons in APEJ is also expected to drive the market.

Market: Key Players

Some of the key players in global MRI guided neurosurgical ablation market Monteris Medical Inc,MRI Interventions and Medtronic.

Key Segments Covered in MRI Guided Neurosurgical Ablation Industry Research

MRI Guided Neurosurgical Ablation Market by Product Type:

  • MRI Guided Laser Therapy Systems
  • MRI Guided RF Ablation Systems
  • MRI Guided Focused Ultrasound Systems
  • Accessories
    • Probes
    • Electrodes

MRI Guided Neurosurgical Ablation Market by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Research Laboratories

MRI Guided Neurosurgical Ablation Market by Region

  • North America MRI Guided Neurosurgical Ablation Market
  • Latin America MRI Guided Neurosurgical Ablation Market
  • Europe MRI Guided Neurosurgical Ablation Market
  • East Asia MRI Guided Neurosurgical Ablation Market
  • South Asia & Pacific MRI Guided Neurosurgical Ablation Market
  • Middle East & Africa (MEA) MRI Guided Neurosurgical Ablation Market

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-2514

Information Source:

https://community.wongcw.com/posts/209936

https://kaalama.org/read-blog/190779

https://talknchat.net/post/1962_iv-poles-market-demand-overview-size-trend-and-key-players-the-global-iv-poles-m.html

https://vhearts.net/post/209729_iv-poles-market-future-demands-regional-developments-and-industry-competitive-la.html#gsc.tab=0

https://addandclick.com/post/281548_preterm-birth-prevention-and-management-market-to-witness-comprehensive-growth-b.html

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Injectable Drug Delivery Market: Top trends driving the industry to reach USD 69.13 Bn

The global injectable drug delivery market is projected at US$ 41.5 Bn in 2022 and is expected to expand at CAGR of 8.9% over 2022–2028, to reach US$ 69.13 Bn by 2028 end. Based on product type, the needle-free injectable drug delivery segment dominated the global injectable drug delivery market in 2017. Moreover, the subtype, prefilled of needle-free injectors segment is expected to have a dominant share of the needle-free type of injectable drug delivery market due to its ease of application. North America is expected to maintain its dominance in the global injectable drug delivery market due to the presence of a large number of manufacturers of injectable drug delivery devices, mostly operating from the U.S.

Increase in prevalence of chronic diseases such as diabetes, cancer and rheumatoid arthritis along with other factors such as need for patient-controlled drug release and increased risk of needle stick injuries are the prominent factors expected to drive the growth of the injectable drug delivery market. Technological advancements have resulted in better product offerings in the injectable drug delivery market. However, some factors such as strict regulatory framework and premium pricing of products are expected to hinder the growth of the injectable drug delivery market. The key trend of the injectable drug delivery market is the increasing demand for point-of-care devices. Injectable drug delivery devices are easy to self-administer and do not require a healthcare professional for administration, which as a result skips the need of hospital visits and relatively lowers the healthcare spending for an individual.

The global injectable drug delivery market has been segmented on the basis of product type, usage, end users and regions. The disposable injectable drug delivery segment is expected to be the most attractive usage segment. Among the three end users, the hospital pharmacies is expected to be the dominant segment due to benefits such as favourable reimbursement policies in most of the countries across the globe.

In terms of value, the global injectable drug delivery market is expected to expand at 8.9% CAGR over the forecast period. With nearly 32% market share, North America was a dominant regional market for injectable drug delivery in 2017, due to growing number of manufacturers in the region and early adoption of new technologies. Western Europe is expected to be the second large market in injectable drug delivery, with Germany, the U.K. and France occupying major shares. APEJ is expected to be third large market for injectable drug delivery, due to requirement of low capital for manufacturing injectable drug delivery.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/sample/rep-gb-393

Key Research Findings

  • Increase in demand for point-of-care devices and reduced reliance on healthcare facilities are driving the growth of the global injectable drug delivery market
  • North America will be the dominant regional market for injectable drug delivery devices due to early adoption of advanced technologies
  • Most of the major players operate from the U.S., which makes the U.S. the leading market for injectable drug delivery devices in North America
  • In Europe, a large number of diabetes patients are switching towards needle-free injectable drug delivery devices from conventional injections since it is a painless process and reduces the risk of needle stick injuries
  • Disposable injectors are the most commonly available type of injectors since they are user friendly and do not require special skills for administration
  • Prefilled needle-free injectors are the most preferred type of injectors since they are much easier to administer than the fillable type
  • Price control for most of the injectable drug delivery devices is fierce. For instance, Mylan was pressurised to launch the generic version of the EpiPen to reduce the price of the product in the market. However, this has declined the revenue of the company.
  • In developed regions, such as North America and Europe, hospitals are the dominant distribution channel due in injectable drug delivery due to the reimbursement policies
  • The growing competition in the emerging market and the rising demand for injectable drug delivery are the future opportunities for the growth and expansion of the injectable drug delivery market.

Browse Full Report:

https://www.futuremarketinsights.com/reports/injectable-drug-delivery-market

 Key Segments:

Product Type:

  • Self-Injectors
  • Needle-free Injectors
  • Auto-Injectors

Usage:

  • Disposable Injectors
  • Reusable Injectors

Distribution Channels:

  • Hospital Pharmacies
  • Retail Pharmacies
  • E-commerce

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/ask-question/rep-gb-393

Information Source:

https://akastars.com/post/261211_iv-poles-market-by-competitive-landscape-swot-analysis-opportunities-and-challen.html

https://lyfepal.com/posts/85984

https://priti-nag.tribe.so/post/iv-poles-market-key-developments-research-methodology-and-top-player-foreca–63490d5f87c804d10d5c95ad

https://webyourself.eu/posts/43636

https://www.rolonet.com/posts/140379

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Canine Arthritis Treatment Market: Top Trends and industry overview to watch for in 2028

The global Canine Arthritis Treatment Market stands at a net worth of US$ 2.39 Bn in 2022. Worldwide demand for canine arthritis treatment medications is predicted to rise at a CAGR of 4.2% and attain a market valuation of US$ 3.05 Bn by 2028. Canine arthritis treatment medicines accounted for 17.2% share of the global rare inflammatory disease treatment market in 2021.

Canine arthritis is a degenerative joint disease that produces inflammation in the joints of dogs as a result of frequent rubbing, cartilage degradation, and long-term joint disease. The knees, elbows, shoulders, hips, and spinal cord are usually the most affected joints in animals. Injuries, overweight, and faulty bone formation are some of the reasons for canine arthritis in dogs.

A notable increase in dog ownership around the world, developing veterinary healthcare infrastructure and rising treatment options for canine arthritis are the key factors for the growth of the global canine arthritis treatment market.

As per the findings of Future Market Insights, the global canine arthritis treatment market is projected to experience significant growth during the forecast period, due to increasing prevalence of obesity induced arthritis among dogs and rise in awareness about the companion animal health. Moreover, ease in the FDA approval for novel and innovative canine arthritis treatment drugs will create growth opportunities for the market players.

The global canine arthritis treatment market valued in 2019 is estimated at ~ US$ 1.9 Bn, and is expected to increase at a CAGR of ~ 4% during the forecast period of 2019-2029.

Get Sample PDF Brochure: 

https://www.futuremarketinsights.com/reports/sample/rep-gb-3552

Key Takeaways from Canine Arthritis Treatment Market Study

  • Non-steroidal anti-inflammatory medications are referred as a first choice of veterinarian for the treatment of inflammation and pain. These medications are known to have effects, for example, decreasing tingling, allergic reaction, swelling, and pain. Canines approved non-steroidal anti-inflammatory medications have demonstrated acceptable safety profile, which is in contrast to non-approved NSAIDs.
  • Growth prospects of the canine arthritis market are relatively high in North America as compared to other regions, attributed to rise in the adoption rate of canines, increasing veterinary expenditure on their health, and greater awareness about the pet health.
  • Market players remained focused on capitalizing on veterinary hospitals and clinics, as they provide an entire animal care and service support for better pet health.
  • Oral formulations of major non-steroidal anti corticosteroids medications will continue to account for major share of the manufacturers’ bottom lines, in the view of increasing demand for their ease of administration and better animal compliance.

Robust Clinical Development Pipeline to Dictate Stakeholders’ Strategies

Elanco, Ceva Sante Animale, Boehringer Ingelheim are among the leading players in the canine arthritis treatment market. These manufacturers continue to dominate the market landscape of canine arthritis treatment by ensuring product availability, collaborating with the local distributors, strengthening manufacturing facilities, and strategizing R&D for diversification of product portfolio.

Key Segments Of Canine Arthritis Treatment Industry Survey

Canine Arthritis Treatment Market by Treatment:

  • Non-steroidal Anti-inflammatory Drugs (NSAIDs)
  • Opioids
  • Stem Cell Therapy
  • Allogeneic Stem Cells
  • Autologous Stem Cells

Canine Arthritis Treatment Market by Route of Administration:

  • Oral Canine Arthritis Treatment
  • Injectable Canine Arthritis Treatment

Canine Arthritis Treatment Market by Distribution Channel:

  • Veterinary Hospitals & Clinics
  • Retail Pharmacies
  • Drug Stores
  • e-Commerce

Canine Arthritis Treatment Market by Region:

  • North America Canine Arthritis Treatment Market
  • Latin America Canine Arthritis Treatment Market
  • Europe Canine Arthritis Treatment Market
  • East Asia Canine Arthritis Treatment Market
  • South Asia & Pacific Canine Arthritis Treatment Market
  • Middle East & Africa (MEA) Canine Arthritis Treatment Market

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-3552

Table of Content

  1. Executive Summary

1.1. Market Outlook

1.2. Analysis and Recommendations

  1. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

  1. Market Background

3.1. Macro-Economic Factors

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity Analysis

3.1.4. Trends

  1. Market Context

4.1. Global Healthcare Market Outlook

4.2. Global Canine Arthritis Treatment Scenario

4.3. Pet Ownership in European Union (EU)

4.4. Share of Household Owing at least one Dog in European Union (EU)

4.5. Spending on Health of Pets

4.6. Vet care Spending on Dogs

4.7. Key Regulations and Guidelines

  1. Global Canine Arthritis Treatment Market (in Value or Size in US$ Mn) Analysis 2013-2021 and Forecast, 2022-2028

5.1. Historical Market Value (US$ Mn) Analysis, 2013-2021

5.2. Current and Future Market Value (US$ Mn) Projections, 2022-2028

5.2.1. Y-o-Y Growth Trend Analysis

5.2.2. Absolute $ Opportunity Analysis

5.2.3. Market Value Comparison

Inquire Before Buying This Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-3552

Information Source:

https://addandclick.com/post/281532_iv-poles-market-trends-demand-growth-revenue-analysis-report-to-2029-the-global.html

https://www.articlesfactory.com/my/articles/962a4632-7d5e-4814-b308-a349e0d125d2

https://figma-bosnia.tribe.so/post/iv-poles-market-analysis-size-applications-share-trends-forecast-to-2029-th–63490d53643ac04c7f8a9368

https://club.vexanium.com/post/iv-poles-market-status-growth-opportunity-size-trends-key-industry-outlook—63490d8f33207205b536199c

https://www.snipesocial.co.uk/posts/140722

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Veterinary Vaccines Market is anticipated to register a CAGR of 7.2% from 2022- 2026

[193 Pages Report] Immunization and vaccination are accepted as the most cost-effective and viable method of controlling infectious veterinary diseases. Veterinary vaccines play an important role in the reduction of diseases, in both, livestock and companion animals.

Increasing awareness regarding animal health and growing demand for animal protein food products are key factors expected to augur well for the veterinary vaccines market. Veterinary vaccines are witnessing demand upsurge, globally, owing to increasing government-backed initiatives for the prevention of zoonotic diseases.

The global veterinary vaccines market is projected to be valued at US$ 9.1 Bn in 2022, and is expected to witness a CAGR of nearly 7% during the forecast period (2022–2026).

However, the coronavirus (COVID-19) pandemic has exposed the market to several uncertainties. With initial speculations blaming meat products for the transmission, the veterinary vaccines market witnessed a slowdown. That being said, further investigations have revealed that, meat consumption is not responsible for the COVID-19 contagion. As such, the veterinary vaccines market is gradually coming back on track, backed by increasing demand for animal-based products such as eggs, milk, and meat.

“Development of new and effective veterinary vaccines such as recombinant vaccines for infectious, parasitic, and metabolic diseases, and increasing animal disease eradication programs, will boost the growth of the veterinary vaccines market over the coming years.”

Key Takeaways of Veterinary Vaccines Market Study

  • Attenuated live vaccines emerged as the largest segment by product, representing around 24% revenue share in veterinary vaccines market in 2021. Attenuated live vaccines are effective and are widely preferred for the treatment of animal diseases; they are expected to exhibit significant growth over the forecast period.
  • By disease, the foot & mouth disease accounted for the highest revenue in 2021. High prevalence of foot & mouth disease is anticipated to drive demand for veterinary vaccines, worldwide.
  • Veterinary clinics hold over 2/5 share of the veterinary vaccines market value, owing to increasing number of veterinary clinics.
  • Based on species, livestock animals account for a leading revenue share in the veterinary vaccines market, owing to higher demand for livestock vaccines for better quality of meat and processed meat export.
  • Cumulatively, North America and Western Europe contribute over 58% share in the global veterinary vaccines market, with North America leading the pack in terms of revenue share.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-409

Acquisition a Prominent Strategy Adopted by Veterinary Vaccine Manufacturers

The acquisition strategy helps in complementing the vaccine portfolio that adds significant value to an organization. For instance, in June 2016, Boehringer Ingelheim International GmbH signed an agreement with Sanofi’s animal-health business (Merial). In July 2018, Zoetis acquired Nexvet Biopharma. This collaboration strengthened the development platform of mAb therapies and added new alternatives to treat osteoarthritis in companion animals.

Want more insights?

Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels, and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2026. The global veterinary vaccines market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provides compelling insights on the veterinary vaccines market on the basis of product (attenuated live vaccines, conjugate vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines, and recombinant vaccines), disease (anaplasmosis, canine parvovirus, foot & mouth disease, new castle disease, distemper disease, influenza, porcine reproductive & respiratory syndrome (PRRS), and others), distribution channel (veterinary clinics, veterinary hospitals, veterinary research institutes, and retail pharmacies), and species (companion animals, companion animals, and equine), across seven major regions.

Key Segments of Veterinary Vaccines Industry Survey

By Product:

  • Attenuated Live Vaccines
  • Conjugate Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • DNA Vaccines
  • Recombinant Vaccines

By Disease:

  • Anaplasmosis
  • Canine Parvovirus
  • Foot & Mouth Disease
  • New Castle Disease
  • Distemper Disease
  • Influenza
  • Porcine Reproductive & Respiratory Syndrome (PRRS)
  • Others

By Distribution Channel:

  • Veterinary Clinics
  • Veterinary Hospitals
  • Veterinary Research Institutes
  • Retail Pharmacies

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-409

By Species:

  • Companion Animals
    • Canine
    • Avian
    • Feline
  • Livestock Animals
    • Aquatic
    • Bovine
    • Porcine
    • Ovine/Caprine
    • Poultry
  • Equine

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs

Empty Capsules Market totaling a valuation of US$ 2.9 Bn by 2026

[204 Pages Report] Empty capsules are witnessing an adoption upsurge, owing to numerous factors such as limited number of competitors, growing demand from the pharmaceutical sector, standard margin level, and potential opportunities in vegan gelatin-based capsules. Further, faster uptake by the FDA and focus of market players on ramping up production capacity are key factors shaping the growth of the empty capsules market.

Empty capsule manufacturers are progressively targeting specialty markets such as contract manufacturers, generic manufacturers, and pediatric drug manufactures. Increasing penetration of low-cost manufacturers in various countries, and supply contracts of life-saving essential drugs, primarily in developing and emerging countries, are further driving the empty capsules market.

Empty Capsules Market Size (2022) US$ 2.1 Bn
Predicted Revenue Total (2026) US$ 2.9 Bn
Forecasted Growth Rate (2022-2026) 8%
North America Market Share 38.3%

The global empty capsules market is estimated to be valued at US$ 1.9 Bn in 2022, with the market expected to exhibit a CAGR of 8% during the forecast period (2022-2030). The coronavirus (COVID-19) pandemic that has so far claimed the lives of over 200,000 people and infected over 3 million, has forced several countries to declare nationwide lockdowns. This has disturbed supply chains in the empty capsules market, due to logistics paralysis. As such, the market is expected to witness a gradual decline in in 2022.

“Lower labour cost and abundant availability of raw materials are among the key factors driving the empty capsules market in Asia Pacific excluding Japan (APEJ) and Western Europe. In addition, favorable regulatory ecosystem to establish empty capsule manufacturing businesses and lower taxation policies are propelling market growth in APAC.”

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-782

Key Takeaways of Empty Capsules Market Study

  • Greater focus on relieving pressure of supply chain due to demand gap is being tackled by ramping up production capacity; up-scaling is the fundamental strategy outlined for meeting demand in the empty capsules market.
  • Vegetable capsules are the latest innovation and are expected to replace gelatin-based variants. Recently, hard gelatin manufacturers have begun increasing the production of vegetarian capsules at scale.
  • South and East Asian pharmaceutical markets are expected to grow at twice the global average in terms of value, owing to population growth, rising incomes, and improved access to healthcare.
  • The empty capsules market in China is anticipated to exhibit the fastest growth, where per capita spending is anticipated to increase by over 70% in the coming five years.
  • High upfront costs and lower margin levels in empty capsules have resulted in 10%-20% price hike in finished products, registering lower sales for animal-based gelatin products in the recent past.
  • India, with almost 40% growth, is offering value-capture opportunities, owing to good patient recruitment, acceptable quality of services, reasonable cost-quality ratio, existence of regulatory agencies, high standards of care, larger population base, and low cost of labour.
  • Companies manufacturing halal capsules are obtaining halal certification from the Islamic Food and Nutrition Council of America (IFANCA) to capture market shares in Muslim-dominated countries.
  • The empty capsules market is consolidated, with leading manufacturers holding around 70% revenue share. Further, growing prominence of CMOs and large-scale gelatin manufacturers is anticipated to boost the growth engine.
  • Higher volume handling by key players in comparison with local manufacturers, and higher production capabilities and price advantages over non-standard manufacturers, are expected to generate significant revenue pockets.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-782

Key Players Focus on Capacity Expansion, Strategic Acquisitions, and Joint Ventures to Widen Regional Presence

Leading players 

  • ACG Worldwide,
  • Capsugel,
  • Qualicaps, Inc.,
  • Bright Pharma Caps, Inc., and Roxlor LLC,

are concentrating on business expansion through mergers, joint ventures, distribution agreements, and capturing untapped market potential.

  • For example, in 2015, Capsugel increased the production of vegetarian-based capsules by investing US$ 25 Mn across its manufacturing sites.
  • Empty capsule manufacturers are generating high returns from nutraceutical and pharmaceutical industries by supplying non-animal or vegetarian empty capsules, with effective physical properties such as reduced moisture content, best suited for nutrient supplements and hygroscopic drugs.
  • In similar context, empty capsule manufacturers are boosting substantial sales revenue from nutraceutical manufacturers by supplying vegetarian-based empty capsules coupled with fluid filling technology.
  • Top manufacturers of hard gelatin capsules are expanding their production facilities through acquisitions.
  • For instance, Qualicaps completed the acquisition of Genix Industria Farmaceutica Ltd., one of Brazil’s top hard empty capsule manufacturers. The acquisition permits the manufacturer to establish its operating sites in the U.S., Canada, Spain, Japan, and Romania.
    • CapsCanada Corporation also acquired the assets of two additional gelatin manufacturing facilities, and this significant acquisition further merged with the manufacturer’s vertically-integrated production plants, with a total of four (bovine) other gelatin manufacturing facilities.

Additionally, current acquisitions are focused on capacity expansion and manufacturing capabilities of existing empty capsules players to gain market share.

More Valuable Insights on Empty Capsules Market

Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels, and provides an analysis of the latest industry trends in each of the segments from 2015 to 2029. The global empty capsules market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provide compelling insights on the market on the basis of by product type (gelatin (hard)-based capsules and vegetarian-based capsules), raw material (type-A (pork skin), type-B gelatin (animal bones & calf skin), fish bone gelatin, hydroxy propyl methyl cellulose (HPMC), starch materials, and pullulan.), capsule size (size “000” capsules, size “00” capsules, size “0” capsules, size “1” capsules, size “2” capsules, size “3” capsules, size “4” capsules, and size “5” capsules.), route of administration (oral administration and inhalation administration.), and end user (pharmaceutical companies, cosmetic & nutraceutical companies and clinical research organizations (CROs), across seven major regions.

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/782

Key Segments of Empty Capsules Industry Survey Empty Capsules Market by Capsule Size:

  • Size “000” Empty Capsules
  • Size “00” Empty Capsules
  • Size “0” Empty Capsules
  • Size “1” Empty Capsules
  • Size “2” Empty Capsules
  • Size “3” Empty Capsules
  • Size “4” Empty Capsules
  • Size “5” Empty Capsules

Empty Capsules Market by Product Type:

  • Gelatin (Hard)-based Capsules
  • Vegetarian-based Capsules

Empty Capsules Market by Route of Administration:

  • Empty Capsules for Oral Administration
  • Empty Capsules for Inhalation

Empty Capsules Market by Raw Material:

  • Contract Type-A (Pork Skin) Empty Capsules
  • Type-B Gelatin (Animal Bones & Calf Skin) Empty Capsules
  • Fish Bone Gelatin Empty Capsules
  • Empty Hydroxy Propyl Methyl Cellulose (HPMC) Empty Capsules
  • Starch Material Empty Capsules
  • Empty Pullulan Capsules

Empty Capsules Market by End User:

  • Empty Capsules for Pharmaceutical Companies
  • Empty Capsules for Cosmetic & Nutraceutical Companies
  • Empty Capsules for Clinical Research Organizations (CROS)

Empty Capsules Market by Region:

  • North America Empty Capsules Market
  • Latin America Empty Capsules Market
  • Europe Empty Capsules Market
  • East Asia Empty Capsules Market
  • South Asia & Pacific Empty Capsules Market
  • Middle East & Africa (MEA) Empty Capsules Market

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs

Europe Viscosupplementation Market is expected to surpass US$ 11 Bn by 2032

Growing prevalence of osteoarthritis, strong healthcare infrastructure and well established reimbursements are soaring the demand for viscosupplementation market. The Europe viscosupplementation market has been segmented by product type, end user and region.

Rising prevalence of knee osteoarthritis is fuelling demand for effective treatment therapies. Hyaluronic acid-based intra-articular injections have proved to be one of the most preferred choices of treatment for symptomatic knee osteoarthritis. Hyaluronic acid-based intra-articular injections restore normal viscoelastic properties of altered synovial fluid in the knee joint, delivering effective therapeutic effect. The ultimate goal of viscosupplementation is to increase the concentration of hyaluronate in the joints so to restore the altered synovial fluid present in the joints.

Future Market Insights (FMI) delivers key insights on the Europe viscosupplementation market in its upcoming report titled, “Viscosupplementation Market: Europe Industry Analysis and Opportunity Assessment, 2016-2026”. In terms of revenue, the Europe viscosupplementation market is projected to register a healthy CAGR of 5.1% during 2016-2026.

FMI’s report has segmented the market on the basis of product type, end user and region.

Based on product type, the market has been segmented into one injection viscosupplementation, three injection viscosupplementation and five injection viscosupplementation.

Single injection viscosupplementation product type segment is expected to emerge as the most popular segment over the forecast period, driven by better patient compliance as the treatment reduces the need for multiple hospital visits. The segment is expected to register the highest CAGR of 6.7% during the forecast period.

To remain ‘ahead’ of your competitors, request for a sample@ https://www.futuremarketinsights.com/reports/sample/rep-EU-1383

Five injection viscosupplementation product type segment is expected to witness a decline in market share in terms of revenue from 29.0% in 2015 to 23.3% in 2026. This decline is attributed to more incidence of side effects and repeated patient visit requirements associated with five injection viscosupplementation. Reimbursement cutbacks and high injection costs are other factors that can curtail demand for five injection viscosupplementation.

By end-users, the market is segmented into hospitals, ambulatory surgical centres and orthopaedic clinics. Hospitals end-use segment is expected to witness significant demand for viscosupplementation, registering a CAGR of 4.3% over the forecast period. Better reimbursement options and increasing patient preference for single injection cycle for osteoarthritis treatment is expected to drive demand for one injection viscosupplementation in the orthopaedic clinics segment over the forecast period.

Europe Viscosupplementation Market Trends

Key trends in the viscosupplementation market are the use of single injection cycle for osteoarthritis treatment and introduction of new combination products in the market. For example, the product pipeline of major players in the viscosupplementation market involves combining corticosteroid injections, which help in relieving pain associated with osteoarthritis, with long-lasting effects of hyaluronic acid, which lasts for nearly six months. Further, regional competition within EU countries, especially in five injection cycle, is leading to entry of new market players. Europe is a mature market in terms of generic products and it is therefore relatively easier to obtain CE mark in Europe than it is to obtain the U.S. FDA approval.

Western Europe has been estimated to dominate the Europe viscosupplementation market in 2015, attributed to factors such as the presence of key regional players, strong distribution network and better healthcare infrastructure in the region.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-1383

Key Players in Europe Viscosupplementation Market

  • Anika Therapeutics Inc.
  • Sanofi S.A.
  • Zimmer Biomet Holdings
  • Meda AB
  • Ferring B.V
  • Fidia Pharmaceutici S.p.A
  • Bioventus LLC.

We have discussed individual strategies followed by these companies in terms of enhancing product designs, creating new manufacturing facilities, market consolidation and advanced R&D initiatives. The report concludes with key takeaways that could help players already present in the market and new players planning to enter the market in the long run.

Market Dynamics

Growth of the Europe viscosupplementation market is mainly driven by rising obesity rates and growing patient awareness about effective treatment therapies for knee osteoarthritis, coupled with macroeconomic factors such as high unmet patient needs and strengthening of distribution network by key players in the viscosupplementation market.  Other prominent growth drivers include rapidly growing medical technology industry and cost-effectiveness of the treatment. However, economic issues in some Eastern European countries and reimbursement cutbacks are expected to hamper overall growth of the viscosupplementation market in Europe over the forecast period.

Viscosupplementation devices are classified under Class III category in Europe and are considered high-risk devices. They require premarket approval from notified bodies, including private organisations recognised by the European Free Trade Association (EFTA).

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-1383

Key Segments

  • Product Type
    • Single Injection Viscosupplementation
    • Three Injection Viscosupplementation
    • Five Injection Viscosupplementation
  • End User
    • Hospitals
    • Ambulatory Surgical Centres
    • Orthopaedic Clinics

 Key Regions/Countries

  • Western Europe
    • K.
    • France
    • Germany
    • Spain
    • Italy
    • Nordics
    • Rest of Western Europe

Eastern Europe

  • Russia
  • Rest of Eastern Europe

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs

Contrast Media Injectors Market is expected to reach US$ 2.4 Bn by 2030

[269 pages Report] FMI, an ESOMAR-certified market research firm, estimates global contrast media injectors market revenues to reach US$ 1.5 Bn in 2022. In its new study, FMI takes a long-term optimistic view of the market, estimating global revenues to grow at 6.2% CAGR through 2030. The report opines that AI’s growing penetration in the healthcare sector will also rub off on contrast media injectors industry during the next decade.

Data Points Market Insights
Market Value 2021 USD 1.4 Bn
Market Value 2022 USD 1.5 Bn
Market Value 2030 USD 2.4 Bn
CAGR 2022-2030 6.2%
Key Players The key players are Bayer AG, Nemoto Kyorindo Co. Ltd., Mallinckrodt, Bracco Imaging, Ulrich GmBh, Guerbet SA, Medtron AG,
Share of Top 5 Countries 58.1%
To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-823
Key Takeaways of Contrast Media Injectors Market Study 

  • North America is expected to be the most lucrative region and account for more than 32% of revenue in the global contrast media injectors in 2022 and this trend is expected to continue during the forecast period
  • Larger patient pool and increasing government support towards developing healthcare system in Asian countries are expected to propel the growth of the contrast media injectors market in the region
  • AI is expected to speed up the process of injecting contrast media in the forecast period
  • Increasing applications in orthopedic surgeries and neurosurgeries to bolster the market in the forecast period

“Development of advanced contrast media injectors including automated and IT/software technology at low cost is the major focus area of the manufacturers, which provides a competitive advantage” says an FMI Analyst.

New Product Launches and Approval – The Ongoing TrendThe market players are into getting their new products launched as well as approved to stay in the competition and also keep pace with the market scenario (that of continuing to innovate). The constructive steps in this regard are:

  • In Apr 2022, Guerbet announced getting approved by the US FDA for manufacturing gadoterate meglumine (Dotarem) injection inside the US. Till late 2019, this production used to happen outside of the US.
  • In Nov 2021, the US FDA approved an MRI contrast agent “Clariscan” for intravenous use in spine, brain (intracranial), and associated tissues.
  • In Aug 2021, Bracco Diagnostics, Inc. announced getting approved by the US FDA for oral suspension of barium sulfate (Varibar Thin Liquid). The basic use of this contrast agent is detection and assessment of dysphagia.

What else is in the report?Future market insights offer actionable insights and unique perspective on contrast media injectors market in its latest study, presenting historical demand assessment from 2014 – 2021 and projections from 2022–2030 based on product type (angiographic injectors, magnetic resonance imaging (MRI) injectors, computed tomography (CT) injectors), by end-user (hospital, ambulatory surgical centres, diagnostics centres) in seven key regions

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-823

Contrast Media Injectors Market by CategoryBy Product:

  • CT Injectors
  • MRI Injectors
  • Cardio Injectors

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostics Centers

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs

Automated Breast Ultrasound Systems Market Top Trends and industry overview to watch for in 2031

Rising prevalence of breast cancer across the globe and increasing government initiatives undertaken to encourage breast cancer awareness have significantly fuelled the demand for automated breast ultrasound system, according to ESOMAR-certified Future Market Insights’ (FMI) latest research report. As per the study, the global automated breast ultrasound system market is slated to grow at approximately 10% CAGR over the forthcoming decade.

Key manufacturers are actively focusing on developing faster, accurate and minimal invasive ultrasound breast imaging system. According to report published in National Library of Medicine, integration of mammography with automated breast ultrasound system increased the sensitivity of the system to 99.1%.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-606

The combination drastically improves cancer detection rate among dense breasted women and reduces the interpretation time. Prominent manufacturer GE Healthcare launched a new automated breast ultrasound system named “Invenia” in U.S in October 2018. The main function of the system is to identify the presence of mammographically occult cancer especially in women with dense tissues.

With various other developments on cards, the automated breast ultrasound system market is expected to showcase impressive growth between 2021 and 2031.

“Visibly rising consumer inclination towards radiation free imaging and diagnostics systems is likely to intensify sales of automated breast ultrasound system among diagnostics laboratories,” says the FMI analyst.

Key Takeaways from FMI’s Automated Breast Ultrasound Systems Market Study

  • Increasing government investment to promote breast cancer awareness among women will bolster demand across the U.S.
  • The U.K is expected to experience noteworthy growth as governments and private organizations aim at curbing high mortality rate due to breast cancer.
  • Presence of modern healthcare infrastructure will increase automated breast ultrasound system adoption across Germany
  • Saudi Arabia will offer lucrative opportunities owing to rapid urbanization and emergence of advance diagnostics centers.
  • India is expected to exhibit increasing demand owing to increase in per capita income and to growing incidence of breast cancer among women.
  • Hospitals are expected to lead the market driven by faster accessibility modern tool and availability of skilled professionals.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-606

Competitive Landscape

GE Electric Co., Siemens A.G., Hitachi Ltd., SonoCiné Inc., Koninklijke are some prominent players operating in the automated breast ultrasound system market. They are focusing on improving the accuracy of automated breast ultrasound system for faster assessment of cancer screening in addition to getting government approval for their products.

For instance, Hitachi being the global leader in smart life & eco-friendly systems launched its latest automated breast ultrasound system “SOFIA” capable of scanning and acquiring image of the complete breast.

Koninklijke launched Philips EPIQ and Affiniti ultrasound systems as a part of its automated breast ultrasound system product range. Philips EPIQ is laced with an integrated eL18-4 transducer and employs anatomical intelligence for accurate imaging of the breast with high tissue density.

More Insights on the Global Automated Breast Ultrasound Systems Market

In its latest report, FMI offers an unbiased analysis of the global automated breast ultrasound system market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of end user (hospitals, diagnostic imaging laboratories), across seven major regions (North America, Latin America, Western Europe, Eastern Europe, Japan, Asia Pacific excluding Japan,  and Middle East & Africa)

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-606

Key Segments Covered

By End User

  • Hospitals
  • Diagnostic Imaging Laboratories
  •  America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Western Europe
    • EU-5
    • BENELUX (Belgium, Netherlands, Luxembourg)
    • NORDIC (Denmark, Finland, Iceland, Norway, Sweden)
    • Rest of Europe
  • Eastern Europe
    • Poland
    • Russia
    • Rest of Eastern Europe
  • Japan
  • APEJ (Asia Pacific excluding Japan)
    • China
    • India
    • ASEAN Countries
    • Australia & New Zealand
    • Rest of APEJ
  • MEA
    • GCC Countries
    • South Africa
    • Israel
    • Turkey
    • Iran
    • Rest of Middle East & Africa

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs

High Performance Message Infrastructure Market Growth Factors, Opportunities, Ongoing Trends and Key Players 2029

A new research report by Future Market Insights on the high performance message infrastructure market provides significant insights, which consist of the global industry analysis 2014–2021 and forecast 2022 – 2029. According to the market research report, the overall market is projected to expand at a prolific CAGR of 14.4% between 2022 and 2029, surpassing a valuation of US$ 3.37 Bn by 2029.

Furthermore, the global high performance message infrastructure market is anticipated to experience notable growth during the forecast period, due to various driving factors, such as growth in the cloud computing industry, increasing IT infrastructure investment, and rising demand for Big Data and Software Development and Information Technology Operations (DevOps).

Request for a Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2778

Primary trends in the global high-performance message infrastructure marketplace include inclination towards interconnectivity between applications, sites, partners, providers, employees, customers, all devices.

Adoption of Integration Platform-as-a-Service (iPaaS) and event-driven architecture continues to broaden in developing and developed countries all over the world. It is expected that various opportunities will be found for key players in the high performance message infrastructure market over the forecasted period.

According to Future Market Insights’ report, the Big Data use case is anticipated to generate an incremental opportunity of ~US$ 520 Mn for the high performance message infrastructure market during the forecast period of 2019-2029.

Moreover, the event-driven architecture segment is likely to experience high growth rates during the forecast period, owing to growing demand for packaged applications and IT services.

Furthermore, the world is witnessing a significant rise in search-based analysis, predictive model markup language, and text & entity analysis, which, subsequently, is initiating potential growth opportunities for the high performance message infrastructure market.

Request For Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-2778

Key Players Focus on Expanding their Business in APAC

Leading players in the high performance message infrastructure market are focusing on extending their businesses across Asian Pacific countries such as India and China. Increasing investment in digitalization infrastructure by the governments attracts various high performance message infrastructure providers to extend their business in these countries.

Moreover, the healthy economic growth of countries in the region, together with the continuous adoption of advanced technology, including the Internet of Things (IoT), Platform-as-a-Service (PaaS), are creating substantial growth opportunities for the high performance message infrastructure market.

For instance, in August 2019, The Apache Software foundation organized Hadoop community meet up at Beijing, China, with 200 spots available for registration to attend this meet up in person. Participants introduces recent trends in the storage field, such as better scalability and moving towards cloud in the Asia Pacific region.

For instance, in June 2019, TWILIO INC. announced its expansion in the Japanese market. The company also announced new partnerships with seven regional consulting partners.

Buy Report now @ https://www.futuremarketinsights.com/checkout/2778

Cloud-integrated Solutions Playing an Essential Role in Market Growth

There are increasing scope of applications related to software-as-a-service (SaaS) or cloud-based data storage. Such factors have promoted the high performance message infrastructure market players to adopt expansion and product differentiation strategies to gain a distinct competitive edge as well as enhance their market presence, catering to each specific end-use industry.

For this, high performance message infrastructure providers are frequently increasing their investments on product developments and research & development activities to enhance their product offering awareness to the end-user industries.

Key Companies Profiled

  • IBM Corporation
  • SAP SE
  • Oracle Corporation
  • Amazon Web Services, Inc.
  • Red Hat, Inc.
  • Pivotal Software, Inc.
  • TWILIO INC.
  • VMware Inc. (Bitnami)

High Performance Message Infrastructure Market By Category

Component:

  • Hardware
  • Middleware
  • Managed Services

Use Case:

  • Hybrid Cloud
  • Internet of Things (IoT)
  • Integration Platform-as-a-Service(iPaaS)
  • Platform-as-a-Service (PaaS)
  • Application Programming Interfaces (APIs) & Protocols
  • Software Development and Information Technology Operations (DevOps)
  • Big Data
  • Event-Driven Architecture
  • Other Use Cases

Industry:

  • Energy
  • BFSI
  • Government
  • Manufacturing
  • Retail
  • Transport & Logistics
  • Telecommunication
  • Other Industries

Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan
  • Japan
  • Middle East & Africa

About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years

Contact Us:        
Future Market Insights
Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedInTwitterBlogs